Background photo of air particle

ACCESS AND
PATIENT SUPPORT

Getting Started With TYVASO

Getting Started
With TYVASO

Support is in place to help you throughout your treatment journey with TYVASO—including a Virtual Patient Educator through the Archways program.

Portrait of female photographer taking photos outdoorsPortrait of female photographer taking photos outdoors
1
Image of smartphone

REFERRAL

Your doctor will send a referral for your TYVASO prescription to a Specialty Pharmacy (SP). Your SP provider is part of your healthcare team and focuses on providing you with in-home training and 24-hour support.

Image of info icon

Answer the call!

When they first reach out to you, the SP provider may call you from an 866 or 877 number that you may not recognize. It’s important to answer the call because they may not be able to leave a message for you due to privacy rules. Since they cannot get the medicine to you unless they speak to you, be sure to answer the call to get started and to stay on treatment.

2

INSURANCE

Your SP provider will process your referral and contact your insurance company to determine and verify coverage for you.

3

APPROVAL

Your SP provider will contact you to review your coverage and benefits, and if you don’t have insurance, they can help you explore other financial options. Once your referral is approved, they will work with you to coordinate delivery of TYVASO.

4

DELIVERY AND DEMONSTRATION

Your SP nurse will contact you to schedule a virtual or in-person appointment at your home to teach you how to use TYVASO. Your TYVASO supplies will be delivered a couple of days before your appointment.

5

FOLLOW-UP AND REFILLS

Your SP nurse can arrange follow-up visits to support you as you get used to taking TYVASO. Every 4 weeks, you’ll receive a refill shipment of supplies.

TYVASO DPI and the TYVASO nebulizer are available only through the following Specialty Pharmacy providers:

You are now leaving the Tyvaso.com website

This link will take you to a site maintained by a third party who is solely responsible for the site’s content. Click CONTINUE to proceed or CLOSE to return to www.TYVASO.com.

CONTINUE
Accredo Specialty Pharmacy

WEBSITE

You are now leaving the Tyvaso.com website

This link will take you to a site maintained by a third party who is solely responsible for the site’s content. Click CONTINUE to proceed or CLOSE to return to www.TYVASO.com.

CONTINUE
www.accredo.com

You are now leaving the Tyvaso.com website

This link will take you to a site maintained by a third party who is solely responsible for the site’s content. Click CONTINUE to proceed or CLOSE to return to www.TYVASO.com.

CONTINUE

WEBSITE

You are now leaving the Tyvaso.com website

This link will take you to a site maintained by a third party who is solely responsible for the site’s content. Click CONTINUE to proceed or CLOSE to return to www.TYVASO.com.

CONTINUE
www.cvsspecialty.com

THE ARCHWAYS PROGRAM

Support while you begin treatment with TYVASO

Managing Pulmonary Arterial Hypertension (PAH) and getting started on treatment with TYVASO (inhaled treprostinil) can leave you with questions. The United Therapeutics’ Archways program is here to help.

The United Therapeutics’ Archways program is a virtual, educational support program that offers helpful disease information and resources for treatment. Archways is available at no cost to patients and caregivers as you begin your treatment journey with TYVASO.

Connect one-on-one with an Archways Virtual Patient Educator to learn more about your condition and what to expect with your treatment.

To get started, follow one of these three simple steps:

United Therapeutics and the Archways program do not provide medical advice. You are advised to consult with your healthcare provider with any specific questions or concerns about your treatment.

TYVASO Nebulizer Treatment Tracker

Your personal diary for keeping track of your treatment sessions. See how TYVASO fits into your daily life.

DOWNLOAD TREATMENT TRACKER

Join the TYVASO Support Program

If you are considering or are already taking TYVASO, sign up for the TYVASO Support Program to receive helpful tips and resources.

GET STARTED WITH SUPPORT

IMPORTANT SAFETY
INFORMATION

Before you take TYVASO or TYVASO DPI, tell your healthcare provider about all of your medical conditions, including if you:

  • Have low blood pressure
  • Have or have had bleeding problems
EXPAND

IMPORTANT SAFETY
INFORMATION

COLLAPSE

Before you take TYVASO or TYVASO DPI, tell your healthcare provider about all of your medical conditions, including if you:

  • Have low blood pressure
  • Have or have had bleeding problems
  • Have asthma or chronic obstructive pulmonary disease (COPD)
  • Are pregnant or plan to become pregnant. It is not known if either product will harm your unborn baby.
  • Are breastfeeding or plan to breastfeed. It is not known if either product passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment.

Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Either product and other medicines may affect each other.

Especially tell your healthcare provider if you take:

  • Medicines used to treat high blood pressure or heart disease
  • Medicines that decrease blood clotting (anticoagulants)
  • Water pills (diuretics)
  • Gemfibrozil (Lopid®) or rifampin (Rimactane®, Rifadin®, Rifamate®, Rifater®)

What are the possible side effects of TYVASO or TYVASO DPI?

Both products can cause serious side effects, including:

  • Low blood pressure (symptomatic hypotension). If you have low blood pressure, either product may lower your blood pressure more.
  • Bleeding problems. Either product may increase the risk of bleeding, especially in people who take blood thinners (anticoagulants).

The most common side effects of both products are cough, headache, throat irritation and pain, nausea, reddening of the face and neck (flushing), fainting or loss of consciousness, dizziness, diarrhea, and shortness of breath. Like other inhaled prostaglandins, you may have trouble breathing after taking TYVASO or TYVASO DPI because it may cause the muscles around your airway to tighten (bronchospasm). These are not all the possible side effects. Call your doctor for medical advice about side effects or if you have trouble breathing.

You may report side effects to the FDA at

You are now leaving the Tyvaso.com website

This link will take you to a site maintained by a third party who is solely responsible for the site’s content. Click CONTINUE to proceed or CLOSE to return to www.TYVASO.com.

CONTINUE
www.fda.gov/MedWatch
or call 1-800-FDA-1088.

What are TYVASO and TYVASO DPI?

TYVASO (treprostinil) Inhalation Solution and TYVASO DPI (treprostinil) Inhalation Powder are prescription medicines used in adults to treat:

  • Pulmonary arterial hypertension (PAH; WHO Group 1), which is high blood pressure in the arteries of your lungs. TYVASO or TYVASO DPI can improve the ability to exercise. Your ability to exercise decreases 4 hours after taking TYVASO or TYVASO DPI. It is not known if TYVASO or TYVASO DPI is safe and effective in children under 18 years of age.
  • Pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3), which is high blood pressure in the lungs due to inflammation and sometimes scarring in the lungs. TYVASO or TYVASO DPI can improve the ability to exercise.

The risk information provided here is not comprehensive. To learn more about TYVASO or TYVASO DPI, talk with your healthcare provider. Please see Full Prescribing Information for TYVASO or TYVASO DPI, Instructions for Use manuals for TD-100 and TD-300 TYVASO® Inhalation System and TYVASO DPI™ Inhalation Powder, and additional information at www.TYVASO.com or call 1-877-UNITHER (1-877-864-8437).


TYVISIconMAY2022

DPI=dry powder inhaler.

Drug Discard ProgramPrivacy PolicyTerms of UseContact UsSite Map

TYVASO and TYVASO DPI are registered trademarks of United Therapeutics Corporation.

All other brands are trademarks of their respective owners. The makers of these brands are not affiliated with and do not endorse United Therapeutics or its products.

© 2023 United Therapeutics Corporation. All rights reserved. US/TYV/0798

The information contained in this section of the site is clinical in nature and specifically created for healthcare professionals. If you are not a US healthcare professional, please click CLOSE and return to the consumer section of the site.

Yes, I am a US healthcare professional and would like to continue.

Continue
For US Healthcare ProfessionalsOpen Modal Button